{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:16:56Z","timestamp":1792174616826,"version":"4.4.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T00:00:00Z","timestamp":1360022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00406-013-0395-2","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T12:20:19Z","timestamp":1359980419000},"page":"273-284","source":"Crossref","is-referenced-by-count":47,"title":["Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors"],"prefix":"10.1007","volume":"263","author":[{"given":"Alkomiet","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Halene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schahram","family":"Akbarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,5]]},"reference":[{"key":"395_CR1","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/hmg\/ddl253","volume":"15","author":"HM Abdolmaleky","year":"2006","unstructured":"Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT, Thiagalingam S (2006) Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 15:3132\u20133145","journal-title":"Hum Mol Genet"},{"key":"395_CR2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.leukres.2009.08.021","volume":"34","author":"AL Abujamra","year":"2010","unstructured":"Abujamra AL, Dos Santos MP, Roesler R, Schwartsmann G, Brunetto AL (2010) Histone deacetylase inhibitors: a new perspective for the treatment of leukemia. Leuk Res 34:687\u2013695","journal-title":"Leuk Res"},{"key":"395_CR3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brainresrev.2006.04.001","volume":"52","author":"S Akbarian","year":"2006","unstructured":"Akbarian S, Huang HS (2006) Molecular and cellular mechanisms of altered GAD1\/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 52:293\u2013304","journal-title":"Brain Res Rev"},{"key":"395_CR4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archpsyc.62.8.829","volume":"62","author":"S Akbarian","year":"2005","unstructured":"Akbarian S, Ruehl MG, Bliven E, Luiz LA, Peranelli AC, Baker SP, Roberts RC, Bunney WE Jr, Conley RC, Jones EG, Tamminga CA, Guo Y (2005) Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 62:829\u2013840","journal-title":"Arch Gen Psychiatry"},{"key":"395_CR5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","volume":"42","author":"JM Alarcon","year":"2004","unstructured":"Alarcon JM, Malleret G, Touzani K, Vronskaya S, Ishii S, Kandel ER, Barco A (2004) Chromatin acetylation, memory, and LTP are impaired in CBP+\/\u2212 mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 42:947\u2013959","journal-title":"Neuron"},{"key":"395_CR6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1176\/appi.ajp.163.2.272","volume":"163","author":"MH Allen","year":"2006","unstructured":"Allen MH, Hirschfeld RM, Wozniak PJ, Baker JD, Bowden CL (2006) Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am J Psychiatry 163:272\u2013275","journal-title":"Am J Psychiatry"},{"key":"395_CR7","volume-title":"Schizophrenia","author":"W An der Heiden","year":"2011","unstructured":"An der Heiden W, H\u00e4fner H (2011) Course and outcome. In: Weinberger D, Harrison P (eds) Schizophrenia, 3rd edn. Wiley-Blackwell, Oxford","edition":"3"},{"key":"395_CR8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/jnr.20208","volume":"77","author":"C Aston","year":"2004","unstructured":"Aston C, Jiang L, Sokolov BP (2004) Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77:858\u2013866","journal-title":"J Neurosci Res"},{"key":"395_CR9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/157488610789869111","volume":"5","author":"C Bagnes","year":"2010","unstructured":"Bagnes C, Panchuk PN, Recondo G (2010) Antineoplastic chemotherapy induced QTc prolongation. Curr Drug Saf 5:93\u201396","journal-title":"Curr Drug Saf"},{"key":"395_CR10","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1523\/JNEUROSCI.0079-12.2012","volume":"32","author":"S Bahari-Javan","year":"2012","unstructured":"Bahari-Javan S, Maddalena A, Kerimoglu C, Wittnam J, Held T, Bahr M, Burkhardt S, Delalle I, Kugler S, Fischer A, Sananbenesi F (2012) HDAC1 regulates fear extinction in mice. J Neurosci 32:5062\u20135073","journal-title":"J Neurosci"},{"key":"395_CR11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/npp.2011.61","volume":"36","author":"RM Barrett","year":"2011","unstructured":"Barrett RM, Malvaez M, Kramar E, Matheos DP, Arrizon A, Cabrera SM, Lynch G, Greene RW, Wood MA (2011) Hippocampal focal knockout of CBP affects specific histone modifications, long-term potentiation, and long-term memory. Neuropsychopharmacology 36:1545\u20131556","journal-title":"Neuropsychopharmacology"},{"key":"395_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","volume":"444","author":"JA Baur","year":"2006","unstructured":"Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337\u2013342","journal-title":"Nature"},{"key":"395_CR13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/npp.2009.116","volume":"35","author":"FM Benes","year":"2010","unstructured":"Benes FM (2010) Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology 35:239\u2013257","journal-title":"Neuropsychopharmacology"},{"key":"395_CR14","doi-asserted-by":"crossref","first-page":"10164","DOI":"10.1073\/pnas.0703806104","volume":"104","author":"FM Benes","year":"2007","unstructured":"Benes FM, Lim B, Matzilevich D, Walsh JP, Subburaju S, Minns M (2007) Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci USA 104:10164\u201310169","journal-title":"Proc Natl Acad Sci USA"},{"key":"395_CR15","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","volume":"32","author":"M Beneyto","year":"2007","unstructured":"Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH (2007) Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32:1888\u20131902","journal-title":"Neuropsychopharmacology"},{"key":"395_CR16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature05915","volume":"447","author":"SL Berger","year":"2007","unstructured":"Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447:407\u2013412","journal-title":"Nature"},{"key":"395_CR17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1192\/bjp.bp.108.055731","volume":"195","author":"E Bora","year":"2009","unstructured":"Bora E, Yucel M, Pantelis C (2009) Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. Br J Psychiatry 195:475\u2013482","journal-title":"Br J Psychiatry"},{"key":"395_CR18","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/npp.2010.117","volume":"35","author":"O Bousiges","year":"2010","unstructured":"Bousiges O, Vasconcelos AP, Neidl R, Cosquer B, Herbeaux K, Panteleeva I, Loeffler JP, Cassel JC, Boutillier AL (2010) Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B\/H4 acetylation-dependent transcriptional events in the rat hippocampus. Neuropsychopharmacology 35:2521\u20132537","journal-title":"Neuropsychopharmacology"},{"key":"395_CR19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/138920107783018417","volume":"8","author":"O Bruserud","year":"2007","unstructured":"Bruserud O, Stapnes C, Ersvaer E, Gjertsen BT, Ryningen A (2007) Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cell. Curr Pharm Biotechnol 8:388\u2013400","journal-title":"Curr Pharm Biotechnol"},{"key":"395_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","volume":"36","author":"RW Buchanan","year":"2010","unstructured":"Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino PR, Keller W (2010) The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 36:71\u201393","journal-title":"Schizophr Bull"},{"key":"395_CR21","unstructured":"Celegene (2012) Presribing Information ISTODAX (romidepsin) for injection: Update Manufacturing Information 3\/2012"},{"key":"395_CR22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuropharm.2009.07.027","volume":"57","author":"EI Charych","year":"2009","unstructured":"Charych EI, Liu F, Moss SJ, Brandon NJ (2009) GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders. Neuropharmacology 57:481\u2013495","journal-title":"Neuropharmacology"},{"key":"395_CR23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/YIC.0b013e32834e4c56","volume":"27","author":"A Chiesa","year":"2012","unstructured":"Chiesa A, Chierzi F, De Ronchi D, Serretti A (2012) Quetiapine for bipolar depression: a systematic review and meta-analysis. Int Clin Psychopharmacol 27:76\u201390","journal-title":"Int Clin Psychopharmacol"},{"key":"395_CR24","unstructured":"Co M (2011) Presribing Information ZOLINZA (vorinostat) capsules: Revised 11\/2011"},{"key":"395_CR25","unstructured":"Corporation C (2012) Presribing information ISTODAX (romidepsin) for injection: update manufacturing information 3\/2012"},{"key":"395_CR26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1586\/14737175.9.1.87","volume":"9","author":"E Costa","year":"2009","unstructured":"Costa E, Chen Y, Dong E, Grayson DR, Kundakovic M, Maloku E, Ruzicka W, Satta R, Veldic M, Zhubi A, Guidotti A (2009) GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability. Expert Rev Neurother 9:87\u201398","journal-title":"Expert Rev Neurother"},{"key":"395_CR27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/mp.2010.92","volume":"16","author":"TJ Crow","year":"2011","unstructured":"Crow TJ (2011) The missing genes: what happened to the heritability of psychiatric disorders? Mol Psychiatry 16:362\u2013364","journal-title":"Mol Psychiatry"},{"key":"395_CR28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrm3288","volume":"13","author":"L Daxinger","year":"2012","unstructured":"Daxinger L, Whitelaw E (2012) Understanding transgenerational epigenetic inheritance via the gametes in mammals. Nat Rev Genet 13:153\u2013162","journal-title":"Nat Rev Genet"},{"key":"395_CR29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cell.2006.03.033","volume":"125","author":"M Doi","year":"2006","unstructured":"Doi M, Hirayama J, Sassone-Corsi P (2006) Circadian regulator CLOCK is a histone acetyltransferase. Cell 125:497\u2013508","journal-title":"Cell"},{"key":"395_CR30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","volume":"5","author":"M Dokmanovic","year":"2007","unstructured":"Dokmanovic M, Clarke C, Marks PA (2007) Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5:981\u2013989","journal-title":"Mol Cancer Res"},{"key":"395_CR31","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1073\/pnas.0805493105","volume":"105","author":"E Dong","year":"2008","unstructured":"Dong E, Nelson M, Grayson DR, Costa E, Guidotti A (2008) Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc Natl Acad Sci USA 105:13614\u201313619","journal-title":"Proc Natl Acad Sci USA"},{"key":"395_CR32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jnr.20122","volume":"76","author":"S Dracheva","year":"2004","unstructured":"Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V (2004) GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res 76:581\u2013592","journal-title":"J Neurosci Res"},{"key":"395_CR33","doi-asserted-by":"crossref","unstructured":"Duncan CE, Webster MJ, Rothmond DA, Bahn S, Elashoff M, Shannon Weickert C (2010) Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. J Psychiatr Res 44(10):678\u2013681","DOI":"10.1016\/j.jpsychires.2009.12.007"},{"key":"395_CR34","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2174\/092986708784534974","volume":"15","author":"A Echaniz-Laguna","year":"2008","unstructured":"Echaniz-Laguna A, Bousiges O, Loeffler JP, Boutillier AL (2008) Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases. Curr Med Chem 15:1263\u20131273","journal-title":"Curr Med Chem"},{"key":"395_CR35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bbagrm.2011.07.002","volume":"1809","author":"TH Ederveen","year":"2011","unstructured":"Ederveen TH, Mandemaker IK, Logie C (2011) The human histone H3 complement anno 2011. Biochim Biophys Acta 1809:577\u2013586","journal-title":"Biochim Biophys Acta"},{"key":"395_CR36","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.2174\/138161207781663064","volume":"13","author":"G Elaut","year":"2007","unstructured":"Elaut G, Rogiers V, Vanhaecke T (2007) The pharmaceutical potential of histone deacetylase inhibitors. Curr Pharm Des 13:2584\u20132620","journal-title":"Curr Pharm Des"},{"key":"395_CR37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tips.2010.09.003","volume":"31","author":"A Fischer","year":"2011","unstructured":"Fischer A, Sananbenesi F, Mungenast A, Tsai LH (2011) Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol Sci 31:605\u2013617","journal-title":"Trends Pharmacol Sci"},{"key":"395_CR38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.schres.2008.04.026","volume":"103","author":"DP Gavin","year":"2008","unstructured":"Gavin DP, Kartan S, Chase K, Grayson DR, Sharma RP (2008) Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophr Res 103:330\u2013332","journal-title":"Schizophr Res"},{"key":"395_CR39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pbb.2010.11.009","volume":"99","author":"DC Goff","year":"2010","unstructured":"Goff DC, Hill M, Barch D (2010) The treatment of cognitive impairment in schizophrenia. Pharmacol Biochem Behav 99:245\u2013253","journal-title":"Pharmacol Biochem Behav"},{"key":"395_CR40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.schres.2004.09.008","volume":"72","author":"JM Gold","year":"2004","unstructured":"Gold JM (2004) Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 72:21\u201328","journal-title":"Schizophr Res"},{"issue":"Suppl 1","key":"395_CR41","first-page":"S91","volume":"83","author":"M Gottlicher","year":"2004","unstructured":"Gottlicher M (2004) Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. Ann Hematol 83(Suppl 1):S91\u2013S92","journal-title":"Ann Hematol"},{"key":"395_CR42","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M Gottlicher","year":"2001","unstructured":"Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG, Heinzel T (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969\u20136978","journal-title":"EMBO J"},{"key":"395_CR43","doi-asserted-by":"crossref","unstructured":"Govindarajan N, Rao P, Burkhardt S, Sananbenesi F, Schl\u00fcter OM, Bradke F, Lu J, Fischer A (2013) Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer\u2019s disease. EMBO Mol Med 5(1):52\u201363. doi: 10.1002\/emmm.201201923","DOI":"10.1002\/emmm.201201923"},{"key":"395_CR44","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","volume":"483","author":"J Graff","year":"2012","unstructured":"Graff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, Nieland TJ, Fass DM, Kao PF, Kahn M, Su SC, Samiei A, Joseph N, Haggarty SJ, Delalle I, Tsai LH (2012) An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483:222\u2013226","journal-title":"Nature"},{"key":"395_CR45","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1073\/pnas.0503736102","volume":"102","author":"DR Grayson","year":"2005","unstructured":"Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A, Costa E (2005) Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci USA 102:9341\u20139346","journal-title":"Proc Natl Acad Sci USA"},{"key":"395_CR46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/mol.109.061333","volume":"77","author":"DR Grayson","year":"2010","unstructured":"Grayson DR, Kundakovic M, Sharma RP (2010) Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol Pharmacol 77:126\u2013135","journal-title":"Mol Pharmacol"},{"key":"395_CR47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","volume":"153","author":"MF Green","year":"1996","unstructured":"Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321\u2013330","journal-title":"Am J Psychiatry"},{"key":"395_CR48","first-page":"1343","volume":"62","author":"KS Griswold","year":"2000","unstructured":"Griswold KS, Pessar LF (2000) Management of bipolar disorder. Am Fam Physician 62:1343\u20131358","journal-title":"Am Fam Physician"},{"key":"395_CR49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","volume":"459","author":"JS Guan","year":"2009","unstructured":"Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459:55\u201360","journal-title":"Nature"},{"key":"395_CR50","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuropharm.2010.10.021","volume":"60","author":"A Guidotti","year":"2011","unstructured":"Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, Grayson DR, Matrisciano F, Pinna G, Satta R, Sharma RP, Tremolizzo L, Tueting P (2011) Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60:1007\u20131016","journal-title":"Neuropharmacology"},{"key":"395_CR51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-005-2212-8","volume":"180","author":"A Guidotti","year":"2005","unstructured":"Guidotti A, Auta J, Davis JM, Dong E, Grayson DR, Veldic M, Zhang X, Costa E (2005) GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology 180:191\u2013205","journal-title":"Psychopharmacology"},{"key":"395_CR52","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1073\/pnas.081071198","volume":"98","author":"Y Hakak","year":"2001","unstructured":"Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98:4746\u20134751","journal-title":"Proc Natl Acad Sci USA"},{"key":"395_CR53","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.drudis.2007.07.023","volume":"12","author":"TB Halene","year":"2007","unstructured":"Halene TB, Siegel SJ (2007) PDE inhibitors in psychiatry\u2014future options for dementia, depression and schizophrenia? Drug Discov Today 12:870\u2013878","journal-title":"Drug Discov Today"},{"key":"395_CR54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature08162","volume":"460","author":"SS Hammoud","year":"2009","unstructured":"Hammoud SS, Nix DA, Zhang H, Purwar J, Carrell DT, Cairns BR (2009) Distinctive chromatin in human sperm packages genes for embryo development. Nature 460:473\u2013478","journal-title":"Nature"},{"key":"395_CR55","doi-asserted-by":"crossref","unstructured":"Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibault P, M\u00f6ller HJ (2013) World Federation of Societies of Biological Psychiatry (WFSBP): Guidelines for biological treatment of schizophrenia, Part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry 14(1):2\u201344. doi: 10.3109\/15622975.2012.739708","DOI":"10.3109\/15622975.2012.739708"},{"key":"395_CR56","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","volume":"13","author":"A Hasan","year":"2012","unstructured":"Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Moller HJ (2012) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry 13:318\u2013378","journal-title":"World J Biol Psychiatry"},{"key":"395_CR57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2011.05.017","volume":"224","author":"A Hasan","year":"2011","unstructured":"Hasan A, Nitsche MA, Rein B, Schneider-Axmann T, Guse B, Gruber O, Falkai P, Wobrock T (2011) Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation. Behav Brain Res 224:15\u201322","journal-title":"Behav Brain Res"},{"key":"395_CR58","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1176\/appi.ajp.2007.07081223","volume":"165","author":"T Hashimoto","year":"2008","unstructured":"Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, Lewis DA (2008) Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 165:479\u2013489","journal-title":"Am J Psychiatry"},{"key":"395_CR59","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1037\/0894-4105.12.3.426","volume":"12","author":"RW Heinrichs","year":"1998","unstructured":"Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12:426\u2013445","journal-title":"Neuropsychology"},{"key":"395_CR60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archpsyc.59.7.631","volume":"59","author":"SE Hemby","year":"2002","unstructured":"Hemby SE, Ginsberg SD, Brunk B, Arnold SE, Trojanowski JQ, Eberwine JH (2002) Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry 59:631\u2013640","journal-title":"Arch Gen Psychiatry"},{"key":"395_CR61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1600-0404.108.s180.4.x","volume":"180","author":"E Hirsch","year":"2003","unstructured":"Hirsch E, Schmitz B, Carreno M (2003) Epilepsy, antiepileptic drugs (AEDs) and cognition. Acta Neurol Scand Suppl 180:23\u201332","journal-title":"Acta Neurol Scand Suppl"},{"key":"395_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033291711000742","volume":"42","author":"M Hoe","year":"2012","unstructured":"Hoe M, Nakagami E, Green MF, Brekke JS (2012) The causal relationships between neurocognition, social cognition and functional outcome over time in schizophrenia: a latent difference score approach. Psychol Med 42:1\u201313","journal-title":"Psychol Med"},{"key":"395_CR63","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.biopsych.2008.09.017","volume":"65","author":"DJ Holt","year":"2009","unstructured":"Holt DJ, Lebron-Milad K, Milad MR, Rauch SL, Pitman RK, Orr SP, Cassidy BS, Walsh JP, Goff DC (2009) Extinction memory is impaired in schizophrenia. Biol Psychiatry 65:455\u2013463","journal-title":"Biol Psychiatry"},{"key":"395_CR64","volume-title":"Schizophenia\u2014current science and clinical practice","author":"WP Horan","year":"2011","unstructured":"Horan WP, Kern RS, Harvey PO, Green MF (2011) Neurocognition, social cogniton, and functional outcome in schizophrenia. In: Gaebel W (ed) Schizophenia\u2014current science and clinical practice. Wiley, Chichester"},{"key":"395_CR65","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.103.055541","volume":"307","author":"E Hu","year":"2003","unstructured":"Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, Zhang GF, Johanson K, Liu R, Lago A, Hofmann G, Macarron R, De Los Frailes M, Perez P, Krawiec J, Winkler J, Jaye M (2003) Identification of novel isoform-selective inhibitors within class I histone deacetylases. J Pharmacol Exp Ther 307:720\u2013728","journal-title":"J Pharmacol Exp Ther"},{"key":"395_CR66","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1371\/journal.pone.0000809","volume":"2","author":"HS Huang","year":"2007","unstructured":"Huang HS, Akbarian S (2007) GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS One 2:e809","journal-title":"PLoS One"},{"key":"395_CR67","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1523\/JNEUROSCI.3272-07.2007","volume":"27","author":"HS Huang","year":"2007","unstructured":"Huang HS, Matevossian A, Whittle C, Kim SY, Schumacher A, Baker SP, Akbarian S (2007) Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci 27:11254\u201311262","journal-title":"J Neurosci"},{"key":"395_CR68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/11591280-000000000-00000","volume":"11","author":"T Iannitti","year":"2011","unstructured":"Iannitti T, Palmieri B (2011) Clinical and experimental applications of sodium phenylbutyrate. Drugs R D 11:227\u2013249","journal-title":"Drugs R D"},{"key":"395_CR69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.pharmtox.010909.105851","volume":"51","author":"HM Ibrahim","year":"2011","unstructured":"Ibrahim HM, Tamminga CA (2011) Schizophrenia: treatment targets beyond monoamine systems. Annu Rev Pharmacol Toxicol 51:189\u2013209","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"395_CR70","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1523\/JNEUROSCI.0766-05.2005","volume":"25","author":"K Iwamoto","year":"2005","unstructured":"Iwamoto K, Bundo M, Yamada K, Takao H, Iwayama-Shigeno Y, Yoshikawa T, Kato T (2005) DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 25:5376\u20135381","journal-title":"J Neurosci"},{"key":"395_CR71","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cbpa.2009.05.007","volume":"13","author":"JH Kalin","year":"2009","unstructured":"Kalin JH, Butler KV, Kozikowski AP (2009) Creating zinc monkey wrenches in the treatment of epigenetic disorders. Curr Opin Chem Biol 13:263\u2013271","journal-title":"Curr Opin Chem Biol"},{"key":"395_CR72","doi-asserted-by":"crossref","unstructured":"Kano S, Colantuoni C, Han F, Zhou Z, Yuan Q, Wilson A, Takayanagi Y, Lee Y, Rapoport J, Eaton W, Cascella N, Ji H, Goldman D, Sawa A (2012) Genome-wide profiling of multiple histone methylations in olfactory cells: further implications for cellular susceptibility to oxidative stress in schizophrenia. Mol Psychiatry. doi: 10.1038\/mp.2012.120","DOI":"10.1038\/mp.2012.120"},{"key":"395_CR73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.schres.2005.06.007","volume":"79","author":"P Katsel","year":"2005","unstructured":"Katsel P, Davis KL, Haroutunian V (2005) Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res 79:157\u2013173","journal-title":"Schizophr Res"},{"key":"395_CR74","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","volume":"7","author":"AG Kazantsev","year":"2008","unstructured":"Kazantsev AG, Thompson LM (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7:854\u2013868","journal-title":"Nat Rev Drug Discov"},{"key":"395_CR75","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","volume":"409","author":"N Khan","year":"2008","unstructured":"Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, Finn PW, Collins LS, Tumber A, Ritchie JW, Jensen PB, Lichenstein HS, Sehested M (2008) Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 409:581\u2013589","journal-title":"Biochem J"},{"key":"395_CR76","doi-asserted-by":"crossref","first-page":"24685","DOI":"10.1074\/jbc.M110.217083","volume":"286","author":"SM Kinney","year":"2011","unstructured":"Kinney SM, Chin HG, Vaisvila R, Bitinaite J, Zheng Y, Esteve PO, Feng S, Stroud H, Jacobsen SE, Pradhan S (2011) Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. J Biol Chem 286:24685\u201324693","journal-title":"J Biol Chem"},{"key":"395_CR77","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2004.06.002","volume":"42","author":"E Korzus","year":"2004","unstructured":"Korzus E, Rosenfeld MG, Mayford M (2004) CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42:961\u2013972","journal-title":"Neuron"},{"key":"395_CR78","first-page":"489","volume":"15","author":"G Kouraklis","year":"2006","unstructured":"Kouraklis G, Theocharis S (2006) Histone deacetylase inhibitors: a novel target of anticancer therapy (review). Oncol Rep 15:489\u2013494","journal-title":"Oncol Rep"},{"key":"395_CR79","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693\u2013705","journal-title":"Cell"},{"key":"395_CR80","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1176\/appi.ajp.2009.10030434","volume":"167","author":"V Krishnan","year":"2010","unstructured":"Krishnan V, Nestler EJ (2010) Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 167:1305\u20131320","journal-title":"Am J Psychiatry"},{"key":"395_CR81","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.108.051763","volume":"75","author":"M Kundakovic","year":"2009","unstructured":"Kundakovic M, Chen Y, Guidotti A, Grayson DR (2009) The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol 75:342\u2013354","journal-title":"Mol Pharmacol"},{"key":"395_CR82","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nn.3181","volume":"15","author":"M Kurita","year":"2012","unstructured":"Kurita M, Holloway T, Garcia-Bea A, Kozlenkov A, Friedman AK, Moreno JL, Heshmati M, Golden SA, Kennedy PJ, Takahashi N, Dietz DM, Mocci G, Gabilondo AM, Hanks J, Umali A, Callado LF, Gallitano AL, Neve RL, Shen L, Buxbaum JD, Han MH, Nestler EJ, Meana JJ, Russo SJ, Gonzalez-Maeso J (2012) HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci 15:1245\u20131254","journal-title":"Nat Neurosci"},{"key":"395_CR83","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1037\/0735-7044.121.5.1125","volume":"121","author":"KM Lattal","year":"2007","unstructured":"Lattal KM, Barrett RM, Wood MA (2007) Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav Neurosci 121:1125\u20131131","journal-title":"Behav Neurosci"},{"key":"395_CR84","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuron.2012.06.016","volume":"75","author":"H Lee","year":"2012","unstructured":"Lee H, Dvorak D, Kao HY, Duffy AM, Scharfman HE, Fenton AA (2012) Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model. Neuron 75:714\u2013724","journal-title":"Neuron"},{"key":"395_CR85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.ajp.161.1.1","volume":"161","author":"AF Lehman","year":"2004","unstructured":"Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J (2004) Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 161:1\u201356","journal-title":"Am J Psychiatry"},{"key":"395_CR86","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1523\/JNEUROSCI.5467-07.2008","volume":"28","author":"Y Leng","year":"2008","unstructured":"Leng Y, Liang MH, Ren M, Marinova Z, Leeds P, Chuang DM (2008) Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci 28:2576\u20132588","journal-title":"J Neurosci"},{"key":"395_CR87","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","volume":"6","author":"DA Lewis","year":"2005","unstructured":"Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312\u2013324","journal-title":"Nat Rev Neurosci"},{"key":"395_CR88","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.gde.2011.01.022","volume":"21","author":"G Li","year":"2011","unstructured":"Li G, Reinberg D (2011) Chromatin higher-order structures and gene regulation. Curr Opin Genet Dev 21:175\u2013186","journal-title":"Curr Opin Genet Dev"},{"key":"395_CR89","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1471-4159.2004.02569.x","volume":"90","author":"J Li","year":"2004","unstructured":"Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, Konradi C, Akbarian S (2004) Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem 90:1117\u20131131","journal-title":"J Neurochem"},{"key":"395_CR90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tig.2006.02.004","volume":"22","author":"Q Li","year":"2006","unstructured":"Li Q, Barkess G, Qian H (2006) Chromatin looping and the probability of transcription. Trends Genet 22:197\u2013202","journal-title":"Trends Genet"},{"key":"395_CR91","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.cell.2011.10.054","volume":"147","author":"S Libert","year":"2011","unstructured":"Libert S, Pointer K, Bell EL, Das A, Cohen DE, Asara JM, Kapur K, Bergmann S, Preisig M, Otowa T, Kendler KS, Chen X, Hettema JM, van den Oord EJ, Rubio JP, Guarente L (2011) SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell 147:1459\u20131472","journal-title":"Cell"},{"key":"395_CR92","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209\u20131223","journal-title":"N Engl J Med"},{"key":"395_CR93","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5603\/CJ.2012.0078","volume":"19","author":"DR Lynch Jr","year":"2012","unstructured":"Lynch DR Jr, Washam JB, Newby LK (2012) QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature. Cardiol J 19:434\u2013438","journal-title":"Cardiol J"},{"key":"395_CR94","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00702-008-0156-y","volume":"116","author":"D Martins-de-Souza","year":"2009","unstructured":"Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Marangoni S, Novello JC, Maccarrone G, Turck CW, Dias-Neto E (2009) Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J Neural Transm 116:275\u2013289","journal-title":"J Neural Transm"},{"key":"395_CR95","doi-asserted-by":"crossref","first-page":"148046","DOI":"10.1155\/2011\/148046","volume":"2011","author":"R Masetti","year":"2011","unstructured":"Masetti R, Serravalle S, Biagi C, Pession A (2011) The role of HDACs inhibitors in childhood and adolescence acute leukemias. J Biomed Biotechnol 2011:148046","journal-title":"J Biomed Biotechnol"},{"key":"395_CR96","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1523\/JNEUROSCI.5052-10.2011","volume":"31","author":"SC McQuown","year":"2011","unstructured":"McQuown SC, Barrett RM, Matheos DP, Post RJ, Rogge GA, Alenghat T, Mullican SE, Jones S, Rusche JR, Lazar MA, Wood MA (2011) HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci 31:764\u2013774","journal-title":"J Neurosci"},{"key":"395_CR97","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nlm.2011.04.005","volume":"96","author":"SC McQuown","year":"2011","unstructured":"McQuown SC, Wood MA (2011) HDAC3 and the molecular brake pad hypothesis. Neurobiol Learn Mem 96:27\u201334","journal-title":"Neurobiol Learn Mem"},{"key":"395_CR98","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-0173(99)00044-2","volume":"31","author":"JH Meador-Woodruff","year":"2000","unstructured":"Meador-Woodruff JH, Healy DJ (2000) Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev 31:288\u2013294","journal-title":"Brain Res Brain Res Rev"},{"key":"395_CR99","unstructured":"Merck (2011) Presribing information ZOLINZA (vorinostat) capsules: revised 11\/2011"},{"key":"395_CR100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1037\/a0014708","volume":"23","author":"RI Mesholam-Gately","year":"2009","unstructured":"Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ (2009) Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 23:315\u2013336","journal-title":"Neuropsychology"},{"key":"395_CR101","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajhg.2008.01.008","volume":"82","author":"J Mill","year":"2008","unstructured":"Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia P, Assadzadeh A, Flanagan J, Schumacher A, Wang SC, Petronis A (2008) Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 82:696\u2013711","journal-title":"Am J Hum Genet"},{"key":"395_CR102","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","volume":"17","author":"S Miyamoto","year":"2012","unstructured":"Miyamoto S, Miyake N, Jarskog LF, Fleischhacker WW, Lieberman JA (2012) Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol Psychiatry 17:1206\u20131227","journal-title":"Mol Psychiatry"},{"key":"395_CR103","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archpsyc.56.8.749","volume":"56","author":"S Mohamed","year":"1999","unstructured":"Mohamed S, Paulsen JS, O\u2019Leary D, Arndt S, Andreasen N (1999) Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry 56:749\u2013754","journal-title":"Arch Gen Psychiatry"},{"key":"395_CR104","doi-asserted-by":"crossref","first-page":"e19958","DOI":"10.1371\/journal.pone.0019958","volume":"6","author":"MS Monsey","year":"2011","unstructured":"Monsey MS, Ota KT, Akingbade IF, Hong ES, Schafe GE (2011) Epigenetic alterations are critical for fear memory consolidation and synaptic plasticity in the lateral amygdala. PLoS One 6:e19958","journal-title":"PLoS One"},{"key":"395_CR105","doi-asserted-by":"crossref","unstructured":"Mouri A, Nagai T, Ibi D, Yamada K (2012) Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules. Neurobiol Dis. doi: 10.1016\/j.nbd.2012.10.025","DOI":"10.1016\/j.nbd.2012.10.025"},{"key":"395_CR106","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneumeth.2010.08.032","volume":"193","author":"PJ Narayan","year":"2010","unstructured":"Narayan PJ, Dragunow M (2010) High content analysis of histone acetylation in human cells and tissues. J Neurosci Methods 193:54\u201361","journal-title":"J Neurosci Methods"},{"key":"395_CR107","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biopsych.2011.01.032","volume":"70","author":"B Olabi","year":"2011","unstructured":"Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM (2011) Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry 70:88\u201396","journal-title":"Biol Psychiatry"},{"key":"395_CR108","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1037\/0894-4105.11.3.437","volume":"11","author":"BW Palmer","year":"1997","unstructured":"Palmer BW, Heaton RK, Paulsen JS, Kuck J, Braff D, Harris MJ, Zisook S, Jeste DV (1997) Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 11:437\u2013446","journal-title":"Neuropsychology"},{"key":"395_CR109","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1158\/1078-0432.CCR-09-1039","volume":"15","author":"D Palmieri","year":"2009","unstructured":"Palmieri D, Lockman PR, Thomas FC, Hua E, Herring J, Hargrave E, Johnson M, Flores N, Qian Y, Vega-Valle E, Taskar KS, Rudraraju V, Mittapalli RK, Gaasch JA, Bohn KA, Thorsheim HR, Liewehr DJ, Davis S, Reilly JF, Walker R, Bronder JL, Feigenbaum L, Steinberg SM, Camphausen K, Meltzer PS, Richon VM, Smith QR, Steeg PS (2009) Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks. Clin Cancer Res 15:6148\u20136157","journal-title":"Clin Cancer Res"},{"key":"395_CR110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.1186088","volume":"328","author":"S Peleg","year":"2010","unstructured":"Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S, Agis-Balboa RC, Cota P, Wittnam JL, Gogol-Doering A, Opitz L, Salinas-Riester G, Dettenhofer M, Kang H, Farinelli L, Chen W, Fischer A (2010) Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328:753\u2013756","journal-title":"Science"},{"key":"395_CR111","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734\u201336741","journal-title":"J Biol Chem"},{"key":"395_CR112","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659\u2013661","journal-title":"FASEB J"},{"key":"395_CR113","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.psychres.2006.12.019","volume":"151","author":"WT Regenold","year":"2007","unstructured":"Regenold WT, Phatak P, Marano CM, Gearhart L, Viens CH, Hisley KC (2007) Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Res 151:179\u2013188","journal-title":"Psychiatry Res"},{"key":"395_CR114","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7015-10-129","volume":"10","author":"VK Rehan","year":"2012","unstructured":"Rehan VK, Liu J, Naeem E, Tian J, Sakurai R, Kwong K, Akbari O, Torday JS (2012) Perinatal nicotine exposure induces asthma in second generation offspring. BMC Med 10:129","journal-title":"BMC Med"},{"key":"395_CR115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nm.2305","volume":"17","author":"M Rodriguez-Paredes","year":"2011","unstructured":"Rodriguez-Paredes M, Esteller M (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17:330\u2013339","journal-title":"Nat Med"},{"key":"395_CR116","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1515\/BC.2009.131","volume":"390","author":"F Sananbenesi","year":"2009","unstructured":"Sananbenesi F, Fischer A (2009) The epigenetic bottleneck of neurodegenerative and psychiatric diseases. Biol Chem 390:1145\u20131153","journal-title":"Biol Chem"},{"issue":"Suppl 2","key":"395_CR117","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1007\/s00406-011-0242-2","volume":"261","author":"A Schmitt","year":"2011","unstructured":"Schmitt A, Hasan A, Gruber O, Falkai P (2011) Schizophrenia as a disorder of disconnectivity. Eur Arch Psychiatry Clin Neurosci 261(Suppl 2):S150\u2013S154","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"395_CR118","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.schres.2007.09.020","volume":"98","author":"RP Sharma","year":"2008","unstructured":"Sharma RP, Grayson DR, Gavin DP (2008) Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res 98:111\u2013117","journal-title":"Schizophr Res"},{"key":"395_CR119","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archgenpsychiatry.2011.151","volume":"69","author":"HP Shulha","year":"2012","unstructured":"Shulha HP, Cheung I, Whittle C, Wang J, Virgil D, Lin CL, Guo Y, Lessard A, Akbarian S, Weng Z (2012) Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons. Arch Gen Psychiatry 69:314\u2013324","journal-title":"Arch Gen Psychiatry"},{"key":"395_CR120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1022197109569","volume":"69","author":"SM Silverstein","year":"1998","unstructured":"Silverstein SM, Schenkel LS, Valone C, Nuernberger SW (1998) Cognitive deficits and psychiatric rehabilitation outcomes in schizophrenia. Psychiatr Q 69:169\u2013191","journal-title":"Psychiatr Q"},{"key":"395_CR121","doi-asserted-by":"crossref","first-page":"12711","DOI":"10.1073\/pnas.1106264108","volume":"108","author":"M Simon","year":"2011","unstructured":"Simon M, North JA, Shimko JC, Forties RA, Ferdinand MB, Manohar M, Zhang M, Fishel R, Ottesen JJ, Poirier MG (2011) Histone fold modifications control nucleosome unwrapping and disassembly. Proc Natl Acad Sci USA 108:12711\u201312716","journal-title":"Proc Natl Acad Sci USA"},{"key":"395_CR122","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1073\/pnas.0510341103","volume":"103","author":"MV Simonini","year":"2006","unstructured":"Simonini MV, Camargo LM, Dong E, Maloku E, Veldic M, Costa E, Guidotti A (2006) The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci USA 103:1587\u20131592","journal-title":"Proc Natl Acad Sci USA"},{"key":"395_CR123","first-page":"5049","volume":"50","author":"DF Smith","year":"1990","unstructured":"Smith DF, MacGregor JT, Hiatt RA, Hooper NK, Wehr CM, Peters B, Goldman LR, Yuan LA, Smith PA, Becker CE (1990) Micronucleated erythrocytes as an index of cytogenetic damage in humans: demographic and dietary factors associated with micronucleated erythrocytes in splenectomized subjects. Cancer Res 50:5049\u20135054","journal-title":"Cancer Res"},{"key":"395_CR124","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/schbul\/sbi048","volume":"32","author":"BE Snitz","year":"2006","unstructured":"Snitz BE, Macdonald AW 3rd, Carter CS (2006) Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 32:179\u2013194","journal-title":"Schizophr Bull"},{"key":"395_CR125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1017\/S1461145709991246","volume":"13","author":"JM Tamayo","year":"2010","unstructured":"Tamayo JM, Zarate CA Jr, Vieta E, Vazquez G, Tohen M (2010) Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis. Int J Neuropsychopharmacol 13:813\u2013832","journal-title":"Int J Neuropsychopharmacol"},{"key":"395_CR126","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2011.08.008","volume":"146","author":"M Tan","year":"2011","unstructured":"Tan M, Luo H, Lee S, Jin F, Yang JS, Montellier E, Buchou T, Cheng Z, Rousseaux S, Rajagopal N, Lu Z, Ye Z, Zhu Q, Wysocka J, Ye Y, Khochbin S, Ren B, Zhao Y (2011) Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146:1016\u20131028","journal-title":"Cell"},{"key":"395_CR127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","volume":"102","author":"R Tandon","year":"2008","unstructured":"Tandon R, Keshavan MS, Nasrallah HA (2008) Schizophrenia, \u201cjust the facts\u201d what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 102:1\u201318","journal-title":"Schizophr Res"},{"key":"395_CR128","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1038\/tp.2011.61","volume":"1","author":"B Tang","year":"2011","unstructured":"Tang B, Dean B, Thomas EA (2011) Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders. Transl Psychiatry 1:e64","journal-title":"Transl Psychiatry"},{"key":"395_CR129","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nsmb1338","volume":"14","author":"SD Taverna","year":"2007","unstructured":"Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ (2007) How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol 14:1025\u20131040","journal-title":"Nat Struct Mol Biol"},{"key":"395_CR130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0920-9964(03)00191-9","volume":"69","author":"G Thornicroft","year":"2004","unstructured":"Thornicroft G, Tansella M, Becker T, Knapp M, Leese M, Schene A, Vazquez-Barquero JL (2004) The personal impact of schizophrenia in Europe. Schizophr Res 69:125\u2013132","journal-title":"Schizophr Res"},{"key":"395_CR131","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0140-6736(03)14289-4","volume":"362","author":"D Tkachev","year":"2003","unstructured":"Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362:798\u2013805","journal-title":"Lancet"},{"key":"395_CR132","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1073\/pnas.262658999","volume":"99","author":"L Tremolizzo","year":"2002","unstructured":"Tremolizzo L, Carboni G, Ruzicka WB, Mitchell CP, Sugaya I, Tueting P, Sharma R, Grayson DR, Costa E, Guidotti A (2002) An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci USA 99:17095\u201317100","journal-title":"Proc Natl Acad Sci USA"},{"key":"395_CR133","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1523\/JNEUROSCI.0296-07.2007","volume":"27","author":"CG Vecsey","year":"2007","unstructured":"Vecsey CG, Hawk JD, Lattal KM, Stein JM, Fabian SA, Attner MA, Cabrera SM, McDonough CB, Brindle PK, Abel T, Wood MA (2007) Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci 27:6128\u20136140","journal-title":"J Neurosci"},{"key":"395_CR134","doi-asserted-by":"crossref","first-page":"e19229","DOI":"10.1371\/journal.pone.0019229","volume":"6","author":"Z Wang","year":"2011","unstructured":"Wang Z, Yang D, Zhang X, Li T, Li J, Tang Y, Le W (2011) Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS One 6:e19229","journal-title":"PLoS One"},{"key":"395_CR135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.brainres.2008.03.092","volume":"1218","author":"TU Woo","year":"2008","unstructured":"Woo TU, Kim AM, Viscidi E (2008) Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia. Brain Res 1218:267\u2013277","journal-title":"Brain Res"},{"key":"395_CR136","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1101\/lm.213906","volume":"13","author":"MA Wood","year":"2006","unstructured":"Wood MA, Attner MA, Oliveira AM, Brindle PK, Abel T (2006) A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes. Learn Mem 13:609\u2013617","journal-title":"Learn Mem"},{"key":"395_CR137","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/WNR.0b013e328349739b","volume":"22","author":"Y Wu","year":"2011","unstructured":"Wu Y, Blichowski M, Daskalakis ZJ, Wu Z, Liu CC, Cortez MA, Snead OC 3rd (2011) Evidence that clozapine directly interacts on the GABAB receptor. NeuroReport 22:637\u2013641","journal-title":"NeuroReport"},{"key":"395_CR138","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3940(03)00490-7","volume":"345","author":"E Yildirim","year":"2003","unstructured":"Yildirim E, Zhang Z, Uz T, Chen CQ, Manev R, Manev H (2003) Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus. Neurosci Lett 345:141\u2013143","journal-title":"Neurosci Lett"},{"key":"395_CR139","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrg2905","volume":"12","author":"VW Zhou","year":"2011","unstructured":"Zhou VW, Goren A, Bernstein BE (2011) Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 12:7\u201318","journal-title":"Nat Rev Genet"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-013-0395-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-013-0395-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-013-0395-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T05:47:45Z","timestamp":1562651265000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-013-0395-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,5]]},"references-count":139,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["395"],"URL":"https:\/\/doi.org\/10.1007\/s00406-013-0395-2","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,5]]}}}